Delivery Order SPE2DB24D9238-SPE2DB24FDQHP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,661.00 to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of FASENRA 30 MG/ML SYRINGEML, a specialty pharmaceutical product, with a performance period running through September 5, 2024. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,217.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566250012 ! FASENRA 30 MG/ML SYRINGE. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of...
- This firm fixed-price delivery order worth $2,443.50 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialty medication, with a completion date of September 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 contract is for the delivery of the prescription drug FASENRA 30 MG/ML SYRINGEML, with a period of performance through March 19, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,443.50 on July 22, 2025, for the supply of Fasenra 30 mg/mL syringes. The contract, which has no set-aside designation, is set to be completed by July 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the supply of FASENRA PEN 30 MG/MLML, a pharmaceutical product. This delivery order is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,887.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through November 8, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,330.50 on July 22, 2025, for the supply of Fasenra 30 mg/ml syringes. The contract, with an ultimate completion date of July 23, 2025, was issued without a set-aside designation and funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $39,096.00 by the Defense Logistics Agency (DLA) on June 11, 2025, for the supply of Fasenra 30 mg/ml syringes. This firm fixed-price delivery order, which is expected to be completed by June 12, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,443.50, is a delivery order for the pharmaceutical product FASENRA 30 MG/ML SYRINGE. The contract has no set-aside designation and is for a firm fixed price. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB24FDQHPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Fasenra 30 mg/ml syringes, and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This IDC, under the SPE2DB program, allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has a strong track record of supplying branded and generic prescription drugs, biologics, and medical consumables to the Department of Defense (DoD) and Department of Veterans Affairs (VA), and holds multiple prime vendor contracts for direct distribution of pharmacy services and pharmaceutical items to DoD sites. This particular award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 6/12/24 |